Skip to content

Comparing the effectiveness of two different treatment methods in treating pain in facial muscles and joints of the jaw

Effectiveness of applied relaxation method vs. splint in treatment of temporomandibular disorders in Finnish students

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11790049
Enrollment
123
Registered
2019-03-21
Start date
2011-12-09
Completion date
Unknown
Last updated
2020-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and symptoms of temporomandibular disorders Musculoskeletal Diseases

Interventions

Applied relaxation method and splint treatment. Patients were randomly assigned by computer-generated random number using SPSS software (version 18.0) into two treatment groups. Applied relaxation is

Sponsors

Finnish Student Health Service
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Graduate student at University of Oulu or University of Lapland 2. Age 19 - 35 years 3. Attending Finnish Student Health Service's nurse/doctor/physiotherapist/dentist/dental hygienist appointment complaining of symptoms or signs that could have temporomandibular disorder (TMD) origin 4. No previous diagnosis of muscle or joint-related pain conditions, like fibromyalgia, rheumatic conditions or joint-related psoriasis, or mental disorder 5. Diagnosis of temporomandibular disorder (TMD)

Exclusion criteria

Exclusion criteria: 1. No diagnosis of TMD at baseline examination 2. Diagnosis of muscle or joint-related pain conditions, such as fibromyalgia, rheumatic conditions or joint-related psoriasis 3. Mental disorder

Design outcomes

Primary

MeasureTime frame
Symptoms of TMD (pain on palpation; locking of jaws; joint noises) were measured according to the protocol of Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) Axis I at baseline, 3,- 6- and 12 month follow-ups.

Secondary

MeasureTime frame
At baseline and at 12-month follow-up: 1. Experienced pain measured by visual analog scale (VAS) 2. Non-specific pain symptoms measured by RDC/TMD (Research Diagnostic Criteria for TMD) Axis II (Finnish version) 3. Depression symptoms measured by RDC/TMD Axis II (Finnish version)

Countries

Finland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026